Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (1240)	12/17/1997 9:20:00 PM
From: Rick Costantino	Respond to of 2205

Wednesday December 17, 8:10 pm Eastern Time Company Press Release Advanced Tissue Sciences Winner of the 10th Annual CONNECT Award for Most Innovative New Life Sciences Product SAN DIEGO--(BW HealthWire)--Dec. 17, 1997--Advanced Tissue Sciences (NASDAQ:ATIS - news) was honored at the Tenth Annual Most Innovative New Products Awards Competition presented by UCSD's CONNECT Program in Technology and Entrepreneurship. Advanced Tissue Sciences was recognized in the Life Sciences category for their product Dermagraft-TC(TM), a temporary skin substitute for severe and partial thickness burns. ''We are very excited to be recognized by the CONNECT program,'' stated Gail Naughton, Ph.D., president and COO of Advanced Tissue Sciences. ''San Diego is home to many of the country's leading biotech and hi-tech companies and to be acknowledged as a leader in our community is truly an honor,'' she added. Dermagraft-TC is the first tissue engineered human fibroblast-derived temporary skin substitute. The product which was first approved for marketing in March 1997 provides an innovative option in burn treatment. Compared to traditional therapies which include the use of topical antimicrobials, sterile dressings and cadaver skin, Dermagraft-TC significantly improves recovery time and lowers the risk of infections. In his keynote address, Paul Steiger, managing editor of the Wall Street Journal, commented on the San Diego technology industry, ''I've never seen anything like it. The level of excitement here and intellectual economic vitality of the region is amazing,'' he opened. He added that technology is more vital to the current economy than all other industries combined including the energy industries, and that the technology industry is often the driving force behind the markets today. The Most Innovative New Products Awards were created by UCSD CONNECT in 1988 to recognize the tremendous amount of innovation taking place in San Diego companies. This year's competition included 95 entries in seven categories. Sponsors of this year's competition included Cooley Godward LLP, Price Waterhouse LLP, Imperial Bank, J&H Marsh & McLennan, The San Diego Business Journal and Stellcom Technologies. UCSD CONNECT, a Division of Extended Studies & Public Programs at the University of California, San Diego, was formed in 1985 to encourage and foster growth of high-tech and life sciences companies in the San Diego region. The UCSD program in technology and entrepreneurship is dedicated to connecting emerging biotech and hi-tech companies to industry and resources. Advanced Tissue Sciences Inc. of La Jolla, Calif., is a tissue engineering company utilizing its proprietary core technology to develop and manufacture human tissue products for tissue repair and transplantation. In addition to Dermagraft-TC, the company is also currently developing Dermagraft(R), a permanent human dermal replacement for the treatment of diabetic foot ulcers, as well as a variety of products for cartilage and cardiovascular applications. Contact: Burson-Marsteller Scott Marx, 415/764-1348